SoftOx Solutions AS Stock Oslo Bors
Equities
NO0010811961
Biotechnology & Medical Research
Sales 2021 | 7.9M 719K | Sales 2022 | 7.11M 647K | Capitalization | 241M 21.93M |
---|---|---|---|---|---|
Net income 2021 | -65M -5.91M | Net income 2022 | -71M -6.46M | EV / Sales 2021 | 64.3 x |
Net cash position 2021 | 56.98M 5.19M | Net cash position 2022 | 6.91M 628K | EV / Sales 2022 | 32.9 x |
P/E ratio 2021 |
-8.86
x | P/E ratio 2022 |
-3.39
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 96.54% |
Latest transcript on SoftOx Solutions AS
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Geir Almås
FOU | Founder | - | 12-06-20 |
Harald Sætvedt
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Olav Jarlsby
BRD | Director/Board Member | - | 15-04-16 |
Geir Almås
FOU | Founder | - | 12-06-20 |
Adrian Bignami
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |